Breaking News

BioFocus Adds Senior Director

By Gil Roth | February 11, 2013

Rehse to lead Structural Biology

Dr. Peter Rehse has been named senior director, Structural Biology at BioFocus. He will be based at Chesterford Park, near Cambridge, UK. His responsibilities will include managing the structural biology and fragment-based screening groups within the Biological Sciences division.

Dr. Rehse has joined the company from the Chinese CRO Shanghai Medicilon Inc., where, as vice president, he was responsible for the strategic business and scientific development of the structural biology and structure-based drug design unit. Prior to this, he worked at RIKEN Harima Institute in Japan and has held several academic positions in Japan and Canada.  

“With Peter’s international credibility we will be able to strengthen and grow our structural biology and fragment screening operation,” commented Dr. Kate Hilyard, vice president Biological Sciences, BioFocus. “This hire reflects our ongoing commitment to accelerate our client’s discovery programs through investing in the right people."
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.